Diphtheria in the Dominican Republic: reduction of cases following a

Comments

Description

Transcript

Diphtheria in the Dominican Republic: reduction of cases following a

Investigación original / Original research
Pan American Journal
of Public Health
Diphtheria in the Dominican Republic:
reduction of cases following a
large outbreak
Zacarías Garib,1 M. Carolina Danovaro-Holliday,2 Yira Tavarez,1
Irene Leal,3 and Cristina Pedreira2
Suggested citation
Garib Z, Danovaro-Holliday MC, Tavarez Y, Leal I, Pedreira C. Diphtheria in the Dominican Republic:
Reduction of cases following a large outbreak. Rev Panam Salud Publica. 2015;38(4)292–9.
ABSTRACT
Objective. To describe the most recent outbreak of diphtheria in the Dominican Republic
and the disease’s occurrence and vaccination coverage in 2004–2013.
Methods. Clinical data of diphtheria cases that occurred in 2004 and that met the study’s
case definition were reviewed along with socioeconomic and epidemiological information from
the cases’ families. Univariate and multivariate analyses were performed to assess risk factors
for fatal diphtheria. Routine surveillance and vaccination coverage data are presented.
Results. From January 2004–April 2005, a total of 145 diphtheria cases were reported; 80
(66%) of the 122 cases reported in 2004 met the case definition; 26 were fatal (case–fatality
rate: 32.5%). Incidence was highest in the group 1–4 years of age at 5.3 per 100 000; 62.5%
were male. Of the 80 cases, 61 (76%) where hospitalized in Hospital A, 17 in Hospital B, and
2 in two other hospitals. Earlier onset (first half of 2004), birth order, and tracheotomy were
associated with fatal diphtheria (P < 0.05); cases in Hospital A were also more likely to be fatal
(P = 0.066). The average annual diphtheria incidence was 4.91 cases/1 million people in
2000–2003, climbed to 8.8 cases per million in 2004–2005, and dropped to 0.38 in
2006–2014; no diphtheria cases have been reported since 2011. DTP3 vaccination coverage
ranged from 72%–81% in 2000–2004 and from 81%–89% in 2005–2013.
Conclusions. The 2004–2005 diphtheria outbreak in the Dominican Republic resulted in
important and avoidable morbidity and mortality. Annual cases declined and no cases have
been reported in recent years. Maintaining high vaccination coverage and diligent surveillance
are crucial to preventing diphtheria outbreaks and controlling the disease.
Key words
Diphtheria is an acute bacterial disease
caused by Corynebacterium diphtheriae,
which can cause infection of the naso­
pharynx, result in obstruction of the air­
way, and lead to death. The toxin pro­
Ministry of Health, Santo Domingo, Dominican
Republic.
2
Pan American Health Organization (PAHO),
Regional Office of the World Health Organization
(WHO), Washington, DC, United States of
America. Send correspondence to Carolina
Danovaro, email: [email protected]
3
PAHO Country Office, Santo Domingo, Domini­
can Republic.
1
292
Diphtheria; vaccination; disease outbreaks; Dominican Republic.
duced by the bacteria can also result
in systemic complications of various
organs. Though diphtheria anti-toxin
(DAT) usage, improved treatment, and
widespread immunization with diphthe­
ria toxoid have dramatically reduced
mortality and morbidity, vaccination con­
tinues to be essential to preventing the
disease and avoiding large epidemics.
Prompt recognition and treatment of
diphtheria are very important, as the
early use of DAT is associated with better
outcomes (1–3).
Mass resurgence of diphtheria in
countries of the former Soviet Union
(4–6) and outbreaks in Latin America
and the Caribbean (LAC) in the 1990s (7)
highlighted diphtheria’s morbidity and
mortality impact and the importance of
continuous surveillance—including lab­
oratory confirmation of toxigenic C. diphtheriae, and vaccination activities that
achieve high and homogenous cover­
age. Further­more, in recent years, it has
become very hard to find DAT or a man­
ufacturer able to provide the licensed
Rev Panam Salud Publica 38(4), 2015
Garib et al. • Diphtheria in the Dominican Republic
product in sufficient quantities on an
emergency basis (8–9).
Diphtheria has been largely controlled
in LAC following widespread vaccina­
tion with diphtheria toxoid-containing
vaccines as part of the Expanded Program
on Immunization (EPI) launched in the late
1970s (3, 10, 11). In 2000–2003, approxi­
mately 100 cases were reported in LAC
each year, with the Dominican Republic re­
porting the highest count: an average of 43
cases annually during this period (10, 12). In
2004–2005, a large diphtheria outbreak oc­
curred in the Dominican Republic and Haiti
(453 cases) becoming the largest diphtheria
outbreak in LAC in the 21st century (13, 14).
Following that outbreak, diphtheria cases
and deaths in Haiti have continued to
occur, but in the Dominican Republic, they
have dropped progressively (8, 12).
This report describes the 2004–2005
diphtheria outbreak in the Dominican Re­
public, highlighting the main risk factors
for fatal diphtheria and the lessons learned
regarding outbreak management, preven­
tion and control. It also describes the occur­
rence of the disease and vaccination cover­
age in the country during the last decade.
MATERIALS AND METHODS
Outbreak investigation
All hospitalized cases reported to the
Dominican Republic national vaccinepreventable disease surveillance system
as diphtheria in January 2004–April 2005
were assessed; however, analysis was re­
stricted to cases with disease onset in 2004,
as explained below. A case was defined as
clinically-confirmed if the patient had a
history of a sore throat and a pharyngeal
membrane, and a physician had diag­
nosed it as diphtheria. A case was defined
as confirmed by a laboratory if the patient
had catarrhal symptoms and a culture
positive for C. diphtheriae or if the patient
was epidemiologically linked to a case
with a culture positive for C. diphtheriae.
To describe the characteristics of the
cases and determine risk factors for fatal
diphtheria, parents or guardians of the
reported cases were interviewed using a
standard questionnaire that was a re­
vised version of the routine case-investi­
gation form for diphtheria surveillance,
collecting demographical, clinical, and
epidemiological information. A medical
epidemiologist abstracted clinical data from
hospital charts. Variables recorded in­
cluded age at disease onset; sex; munici­
Rev Panam Salud Publica 38(4), 2015
pality of residency; locality (rural or urban/
peri-urban); vaccination history; monthly
family income (in 2004, US$ 1 = 39.24
Dominican pesos); education of the
mother or guardian; number of persons
living in the household and number of
rooms in the residence; date of symp­
toms onset; hospital of admission and
date of hospitalization; main symptoms
and signs; use, dosage, and start date for
DAT treatment; use of antibiotics and
corticosteroids; laboratory test results;
complications; subjective evaluation of
severity; neck edema; tracheotomy; and
outcome (death or recovery).
For this study, a case was defined as ad­
equately vaccinated if: a vaccination card
or health center record showed that the
person had received three doses if he/she
was less than 18 months of age or three
doses plus at least one booster if older.
Information regarding the follow-up of
household contacts was also recorded, in­
cluding the occurrence of cases among
them, use of prophylactic antibiotics, and
vaccination. The main analysis was lim­
ited to cases reported in 2004 because
these had more complete information.
Few of the cases reported in 2005 had the
revised case-investigation form completed
and their hospitalization chart reviewed.
Nasopharyngeal specimens were cul­
tured using tellurite-containing media at
the bacteriological laboratory in the in­
fectious disease department at the na­
tional children’s reference hospital in
Santo Domingo (Hospital A) and, start­
ing in mid-July 2004, also at the bacterio­
logical laboratory in the provincial hos­
pital of the second largest city in the
Dominican Republic (Hospital B). In
order to confirm the etiology of the
outbreak as diphtheria, and because the
Dominican Republic does not have toxi­
genicity testing capability, 16 isolates
were sent to the diphtheria laboratory
at the Centers for Disease Control
and Prevention (CDC; Atlanta, Georgia,
United States) for real-time polymerase
chain reaction (RT-PCR) confirmation.
Cases and vaccination coverage rates
The numbers of diphtheria cases in
the Dominican Republic for 2000–2003
and 2005–2014 were obtained from the
national vaccine-preventable disease
surveillance system. Population esti­
mates to calculate diphtheria incidence
rates were obtained from the Population
Division of the Economic Commission
Original research
for Latin America and the Caribbean
(ECLAC) (15).
For data on coverage with the third
dose of a diphtheria-tetanus-pertussis
vaccine (DTP3) in children less than 1
year of age, in relation to the outbreak, the
study used 2003 DTP3 coverage rates by
province (31 provinces) and health region
(9 regions) as reported to EPI. For the re­
maining years, national coverage rates
reported from the Dominican Republic to
PAHO/WHO were used (12).
Statistical analyses
Outbreak data were entered into
Microsoft Excel™ (Microsoft Corpora­
tion, Redmond, Washington, United States)
and analyzed using its functions and Epi
Info™ version 3.5 (CDC, Atlanta, Georgia,
United States). A Poisson regression was
used to compare the number of diphthe­
ria cases in 2004 and 2005 with the aver­
age occurrence of cases by epidemiologi­
cal week in 2000–2003, in order to assess
the occurrence of a higher than expected
number of cases. Linear regression was
used to evaluate whether diphtheria inci­
dence by province and health region was
associated with reported DTP3 coverage.
To determine risk factors for fatal diph­
theria, the analyses used chi-square test
and Fischer’s exact test for discrete vari­
ables, as well as Wilcoxon for continuous
variables (bivariate). Finally, a logistic re­
gression (multivariate) was employed to
control for clinical and demographic and
socioeconomic factors. The results present
adjusted odds ratios (OR) with 95% confi­
dence intervals (95%CI) and consider
P < 0.05 to be statistically significant.
This article evaluates an outbreak in­
vestigation using existing data; there­
fore, ethical review was not sought.
RESULTS
Outbreak description
Using 2-week intervals, the number of
diphtheria cases reported in 2004 and
2005 were compared to the average
number reported in 2000–2003. This
showed a statistically significant increase,
with the first higher than expected number
of cases appearing in week 9, 2004, and the
last, in week 16, 2005 (P < 0.001) (Figure 1).
No cutaneous diphtheria was reported.
Of the 145 cases reported in January
2004–April 2005 (week 16), 122 were re­
ported in 2004 and 80 of these (66%) met
293
Original research
Garib et al. • Diphtheria in the Dominican Republic
the case definition, either as clinically
confirmed diphtheria (38 cases) or diph­
theria confirmed by laboratory (42
cases, of which 3 were epidemiologi­
cally linked). All 16 isolated C. diphtheriae tested with RT-PCR and ribotyping
were Corynebacterium diphtheriae biovar
mitis.
The median age of the cases was 3
years, and ranged from 3 months–13
years. Incidence was highest in the 1–4
year age group at 5.3 per 100 000; 62.5%
were male. The median income per
family was approximately US$ 89,
ranging from $18–$1 019 per month.
Education level was primary school or
less for 53 of the 71 guardians (75%) with
this data; 14 had no formal education.
Regarding households, 72% of the cases
lived with at least three children less
than 15 years of age. Of the 80 total cases,
61 were hospitalized in Hospital A; 17 in
Hospital B; and 2 in two other hospitals.
Cases in Hospital A were different from
FIGURE 1. Cases of diphtheria by epidemiological week, Dominican Republic, 2000–2005a
6
5
No. of cases
4
3
2
1
0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52
Epidemiological week
2000–2003
a
2004
2005
Case average for years 2000–2003.
TABLE 1. Selected characteristics of diphtheria cases by hospital, Dominican Republic, 2004
Characteristic
Confirmation criteria
Lab
Clinical
Area
Urban and peri-urban
Rural
Sex
Female
Male
Vaccination status
Up-to-date for age
Unvaccinated or undervaccinated
Parental education
No education
1–8 years
9–12 years
> 12 years
Tracheotomy
Yes
No
Contact vaccination
Yes
No
Contact antibiotic use
Yes
No
294
Hospital A
38
23
39
14
21
40
4
55
13
31
8
2
17
42
55
2
36
20
Other hospitals
P
4
15
12
4
9
10
6
13
1
8
4
4
3
16
22
5
6
11
0.002
0.910
0.308
0.011
0.242
0.117
0.005
0.258
0.032
0.034
Laboratoryconfirmed cases
27
12
11
31
0
41
11
18
4
1
15
25
36
1
19
18
Clinically
confirmed cases
24
6
19
19
10
27
3
21
8
5
5
33
31
6
23
13
P
0.313
0.028
0.000
0.036
0.019
0.018
0.014
0.053
0.278
Rev Panam Salud Publica 38(4), 2015
Garib et al. • Diphtheria in the Dominican Republic
cases in other hospitals in terms of con­
firmation criteria, vaccination history,
case-fatality rate, guardian education,
and contact management (Table 1). The
difference between the confirmation cri­
teria in the two hospital groups is lost
after week 24, when Hospital B started
doing culture for C. diphtheriae.
The median period between symptom
onset and hospitalization was 3 days,
ranging from 0–11 days. The length of
hospitalization for those who recovered
was 7.5 days (median), ranging from 2–37
days. Regarding treatment, of the 70 cases
with information available on the use of
DAT, only two cases did not receive it;
one died upon arrival at the hospital. In
Hospital A, 86% of the cases received high
doses of DAT (≥ 80 000 units), compared
to 39% in other hospitals (P < 0.001). All
cases were given antibiotics in the hospi­
tal, except the case that died upon arrival.
Of the 54 cases for which the antibiotic
administered was recorded, 53 (98%)
received penicillin and 1 received a ceph­
alosporin. Twenty-six cases (48%) also re­
ceived chloramphenicol (all in Hospital
A). For 36 cases, the use of corticosteroids
was also registered, not varying by hospi­
tal. Vaccination with diphtheria toxoidcontaining vaccines upon hospitalization
was not systematically recorded.
Most cases occurred in the National
District, where the capital city of Santo
Domingo is located, and in Santiago,
with 29 and 10 cases, respectively. These
two provinces concentrated approxi­
mately 48% of the 2004 country’s popula­
tion. The remaining 39 cases were dis­
tributed in 18 of the 31 provinces of the
country (in 8 of the country’s 9 health
regions), with variable incidence rates.
Of the 78 cases with vaccination data re­
corded, 10 (13%) were considered to be
adequately vaccinated for their age; all but
one of these children recovered. The ex­
ception was a 15-month old child who had
received three diphtheria toxoid-contain­
ing vaccine doses. No adequately vacci­
nated child had laboratory-confirmed
diphtheria. The national 2003 DTP3 cover­
age reported in the country was 75%
(range: 57%–155% by province and 64%–
95% by health region). No correlation be­
tween diphtheria incidence and routine
DTP3 coverage rates by province or health
region was found (R2 = 0.02; P > 0.438).
Contacts
Vaccination was indicated for house­
hold contacts of 67 (91%) of the 74 cases
Rev Panam Salud Publica 38(4), 2015
Original research
with this information recorded. However,
vaccination follow-up to complete series
was not recorded. The investigation also
noted the frequent indiscriminate vacci­
nation of neighbors, but the magnitude
of this occurrence was not quantified.
Antibiotic prophylaxis was indicated for
the contacts of 41 (57%) of 72 cases with
this information available; however, it
was not indicated for all household mem­
bers in 13 of them. The proportion of
cases whose contacts were given antibi­
otics changed from 35.3% between epide­
miological weeks 1–24 to 76.3% after
week 24 (P = 0.001), when contact man­
agement guidelines were issued.
mends three primary doses of diphtheria
toxoid-containing vaccines at 2, 4, and 6
months, and two booster doses at 18
months and 4 years of age. Reported cov­
erage levels with three doses of DTPcontaining vaccines (DTP3) among chil­
dren less than 1 year of age fluctuated
from 72%–83% between 1994 and 2003,
with marked disparities within the coun­
try. Coverage of booster DTP is not rou­
tinely monitored. DTP3 coverage rates
have shown some increase since 2004,
but until 2013 remained below 90%
(Figure 2).
Fatal diphtheria
The largest outbreak of diphtheria in
the Western Hemisphere this century oc­
curred in 2004–2005 in the Dominican
Republic and in neighboring Haiti.
Following this outbreak, diphtheria inci­
dence in the Dominican Republic pro­
gressively declined until 2012, when for
the first time ever, no diphtheria case
was reported in the country.
The outbreak in the Dominican
Republic was likely the result of several
factors, but mainly due to the existence
of pockets of unvaccinated children.
Most cases lived in low-income urban
areas with difficult access to vaccination
posts. Unlike the resurgence of diphthe­
ria that occurred in the former Soviet
Union (4, 5) and in Ecuador in 1994 (7),
which affected mostly young adults, in
the Dominican Republic, children 1–4
years of age were most at-risk, suggest­
ing that recent low coverage levels were
the main factor responsible for this out­
break. Failures in the cold chain, notably
freezing of diphtheria-containing vac­
cines, may not be ruled-out as a contrib­
uting factor, but the cold chain was not
assessed. Observation also suggested
that urban cases came from new settle­
ments in the outskirts of cities, where
access to health services is limited.
Even though diphtheria was endemic
in the Dominican Republic and case in­
vestigation and follow-up guidelines ex­
isted at the beginning of the outbreak, it
was difficult to implement outbreak con­
trol vaccination activities and to manage
household contacts. Also, the initial ac­
cess to DAT was not smooth.
CFRs were higher than reported in
other settings (1–3, 6), particularly in
Hospital A. Mild cases may not have
been recognized and reported. Also,
Hospital A, being the national children’s
Of the 80 cases, 26 died, resulting in a
case-fatality rate (CFR) of 32.5%. CFR
was highest (41%) at Hospital A (Table
1). The median age of children with fatal
diphtheria was 24 months of age (range:
13 months–8 years). Of the fatal cases, 24
were reported as having complications:
22 respiratory, 1 cardiovascular, and 1
both. The median number of days be­
tween symptom onset and death was 4
days (range: 1–12 days), and between
hospitalization and death was 1 day
(range: 0–4 days). The cause of death
was recorded in the medical chart for
21 cases: “cardiorespiratory arrest” for
10 (47.6%); “respiratory insufficiency”
for 8 (38.1%); and “septic shock,” “toxi­
genic shock,” and “possible myocarditis”
for 1 (4.8%) each.
After the bivariate analysis, the multi­
variate model included the period of oc­
currence of the case, tracheotomy, days
between onset and hospitalization, pres­
ence of cervical edema, presence of com­
plications, hospital, and child’s birth
order in the family. Period of onset, birth
order, and tracheotomy were associated
with fatal diphtheria at P < 0.05; hospital
was associated with a P = 0.066 (Table 2).
Diphtheria incidence and
vaccination coverage
The average annual incidence of diph­
theria in 2000–2003 was 4.91 cases per
1 million. In 2004–2005, it reached 8.8 /
1 million. For the period 2006–2014, it
was reduced to 0.38 / 1 million. Figure 2
shows the number of reported diphthe­
ria cases by year.
In the Dominican Republic, the rout­
ine immunization schedule recom­
DISCUSSION
295
Original research
Garib et al. • Diphtheria in the Dominican Republic
TABLE 2. Factors associated with diphtheria fatal outcome, Dominican Republic, 2004
Overall
Variable
Age in months (m)
or years (y) (n = 80 )
Sex (n = 80)
Zone (n = 69)
Period of onset (n = 80)
Vaccination (n = 78)
Hospital (n = 80)
Maternal (or guardian)
education (n =71)
Crowding (n = 76)
Household
income (US$) (n = 68)
Number of children
(n = 76)
Birth order (n = 75)
Contact with other
case (n = 42)
Days between
symptoms onset and
hospitalization (n =78)
Use of antitoxin (n = 70)
Dose of antitoxin (n = 62)
Days between symptoms
onset and use of
antitoxin (n = 55)
Tracheotomy (n = 78)
General situation (n = 71)
Cervical edema (n = 77)
Complications (n = 76)
Corticosteroids (n = 50)
Antibiotic prior to
hospitalization (n = 66)
296
Median (range)
< 2 years
2–4 years
5–14 years
Male
Female
Rural
Urban
EPI weeks 1–24
EPI weeks 25–52
Adequate
Inadequate
A
B or other
None
Grade 1–8
Grade 9+
Median (range)
1–<3 persons/
room
3–<5 persons/
room
5+ persons/room
Median (range)
≤50
51–100
>100
Median (range)
1–3 children
4–5 children
6+ children
Median (range)
1st or 2nd
3rd or more
Yes
No
Median (range)
0–1 days
2 days
3+ days
Yes
No
<80 000 U
80 000+ U
Median (range)
0–1 days
2 days
>=3 days
Yes
No
Not compromised
Compromised
Toxic
Yes
No
Yes
No
Yes
No
Yes
No
No.
%
3 years
(3m–13y)
21
26.3
34
42.5
25
31.3
50
62.5
30
37.5
18
26.1
51
73.9
34
42.5
46
57.5
10
12.8
68
87.2
61
76.3
19
23.8
14
19.7
39
54.9
18
25.4
3.2 (1.3–20)
26
34.2
29
38.2
21
27.6
89.2 (17.8–1019.4)
20
29.4
18
26.5
30
44.1
3 (1–8)
45
59.2
23
30.3
8
10.5
2 (1–8)
39
52.0
36
48.0
16
38.1
26
61.9
3 (0–11)
14
17.9
17
21.8
47
60.3
68
97.1
2
2.9
18
29.0
44
71.0
3 (0–11)
6
10.9
18
32.7
31
56.4
20
25.6
58
74.4
20
28.2
38
53.5
13
18.3
20
26.0
57
74.0
59
77.6
17
22.4
36
72.0
14
28.0
32
57.1
24
42.9
Deceased
No.
%
24 months
(13m–8y)
10
38.5
9
34.6
7
26.9
19
73.1
7
26.9
6
28.6
15
71.4
14
53.8
12
46.2
1
4.0
24
96.0
24
92.3
2
7.7
5
25.0
12
60.0
3
15.0
3.7 (1.5–9.0)
7
30.4
9
39.1
Recovered
No.
%
42 months
(3m–13y)
11
20.4
25
46.3
18
33.3
31
57.4
23
42.6
12
25.0
36
75.0
20
37.0
34
63.0
9
17.0
44
83.0
37
68.5
17
31.5
9
17.6
27
52.9
15
29.4
3 (1.3–20)
19
35.8
20
37.7
7
30.4
14
26.4
89.2 (17.8–203.9) 82.8 (19.1–1019.4)
5
25.0
15
31.3
6
30.0
12
25.0
9
45.0
21
43.8
4 (2–6)
3 (1–8)
10
43.5
35
66.0
9
39.1
14
26.4
4
17.4
4
7.5
3 (1–8)
2 (1–8)
6
27.3
33
62.3
16
72.7
20
37.7
6
50.0
10
33.3
6
50.0
20
66.7
2 (0–10)
3 (0–11)
5
20.8
9
16.7
8
33.3
9
16.7
11
45.8
36
66.7
19
90.5
49
100.0
2
9.5
0
0.0
3
16.7
14
31.8
15
83.3
30
68.2
2 (1–10)
3 (0–11)
3
16.7
3
8.1
7
38.9
11
29.7
8
44.4
23
62.2
14
58.3
6
11.1
10
41.7
48
88.9
1
4.3
19
39.6
15
65.2
23
47.9
7
30.4
6
12.5
7
30.4
13
24.1
16
69.6
41
75.9
24 100.0
35
67.3
0
0.0
17
32.7
12
75.0
24
70.6
4
25.0
10
29.4
8
47.1
24
61.5
9
52.9
15
38.5
Univariate
Multivariate
Risk
ratio
95%
Confidence
interval
P
value
0.145
Odds
ratio
95%
Confidence
interval
P
value
1.7
0.95
Ref
1.63
Ref
Ref
0.88
1.58
Ref
Ref
3.53
3.74
Ref
2.14
1.85
Ref
Ref
0.79–3.68
0.41–2.19
0.78–3.41
0.40–1.92
0.84–2.97
0.53–23.29
0.97–14.38
0.61–7.41
0.59–5.75
0.17
0.896
0.175
0.756
0.154
0.015
0.019
0.217
0.261
0.75
5.29
1.18–23.71
0.3
1.15
0.50–2.65
0.734
1.24
0.52–2.97
0.83
0.33–2.12
1.11
0.47–2.60
Ref
Ref
1.76
0.83–3.72
2.25
0.93–5.44
Ref
2.89
1.27–6.57
1.63
0.63–4.18
Ref
1.53
0.64–3.65
2.01
0.98–4.14
Ref
Ref
3.58
2.44–5.24
0.53
0.18–1.60
Ref
1.94
0.71–5.26
1.51
0.66–3.46
Ref
4.06
2.16–7.64
Ref
Ref
7.89 1.12–55.52
10.77 1.49–77.65
1.25
0.60–2.58
Ref
Undef
Ref
1.17
0.45–3.01
Ref
0.67
0.30–1.47
Ref
0.633
0.661
0.7
0.89
0.105
0.141
0.186
0.025
0.006
0.315
0.24
0.358
0.067
0.087
0.185
0.136
0.235
0.338
<0.001
0.005
0.001
0.56
0.001
1
0.314
1.24
9.3
0.99–1.54
1.81–47.63
0.53
0.007
Rev Panam Salud Publica 38(4), 2015
Garib et al. • Diphtheria in the Dominican Republic
Original research
FIGURE 2. Reported diphtheria cases and DTP3 coverage rates, the Dominican Republic, 1990–2014a
Cases
DTP3
100
125
90
100
Cases
75
70
% coverage
80
50
60
25
50
14
20
20
13
12
20
20
11
20
10
20
09
20
08
05
04
06
20
07
20
20
20
01
00
02
20
03
20
20
20
19
99
19
98
95
96
19
97
19
19
92
93
19
94
19
19
91
40
19
19
90
0
Year
a
Data for 2014 are preliminary, as of 26 December 2014.
referral hospital, likely received the more
dire cases. The inverse relation observed
between symptoms onset and hospital­
ization, and therefore the earlier use of
DAT, may reflect that only children with
severe diphtheria were diagnosed or that
symptom onset may have occurred ear­
lier than reported, but that the guardian
only reported the symptoms when they
became severe. Also, the decline in CFR
during the second semester of 2004 may
reflect an improvement in case recogni­
tion and management following meet­
ings and the development and circula­
tion of clinical management protocols.
Interestingly, myocarditis, one of the
most common causes of death due to
diphtheria described in the literature
(1–3), was only reported as the cause of
death in one case. This suggests limited
recognition of this condition, confusion
with respiratory complications, limita­
tions in diagnosing myocarditis (by elec­
trocardiogram), lack of proper cause of
death registration, or a mix of these
factors.
Outbreak investigation and control
measures seemed to have had an im­
portant impact on the course of the out­
break and on diphtheria occurrence in
Rev Panam Salud Publica 38(4), 2015
the Dominican Republic. The outbreak
resulted in the revision of diphtheria
case definitions and the epidemiological
case-investigation form; the develop­
ment and update of protocols for clinical
management, specimen collection and
processing; enhanced laboratory diagno­
sis capabilities; improved management
of DAT stocks for prompt availability;
and improved procedures for epidemio­
logical surveillance, case investigation,
and contact management (16). The re­
lease and wide dissemination of revised
guidelines for case and contact manage­
ment likely had a significant impact on
case outcome. Finally, the thorough in­
vestigation of this outbreak allowed for
more focused vaccination interventions.
To control the outbreak, the Dominican
Republic focused the 2005 Vaccination
Week in the Americas (VWA) activities
on completing immunization schedules
nationwide. VWA, which ran during the
last days of April–start of May, coincided
with the end of the outbreak. Countries
of the Americas have continued using
VWA as an opportunity to update vacci­
nation schedules (17, 18).
The reduction of diphtheria incidence
in the Dominican Republic following
the outbreak is encouraging, but without
sustained high vaccination coverage
rates, the risk of resurgence remains.
Neighboring Haiti continues to report
diphtheria cases and deaths (12). In the
Dominican Republic, reported coverage
rates with DTP3 among children less
than 1 year of age following the outbreak
are slightly higher than in years prior,
but they remain < 90%. Catch-up of older
children may be occurring, but this is not
routinely quantified.
Limitations
This outbreak investigation has several
limitations. It is based on the analysis of
surveillance data in the context of an out­
break. Even though routine case investi­
gation was enhanced by interviews and
chart reviews, this was not a “study” with
dedicated personnel. Underdiagnosis and
underreporting was likely widespread, as
case ascertainment was based on passive
surveillance, starting with those cases that
were physician-diagnosed and reported.
Furthermore, our analysis focused only
on hospitalized cases in 2004 and had to
meet a more specific case definition than
the one used regularly in the country.
297
Original research
Also, at the beginning of the outbreak,
laboratory confirmation was only avail­
able in Hospital A. Determining risk fac­
tors for diphtheria occurrence was limited
due to the lack of a comparison group.
Regarding vaccination status of cases,
even though local health centers were vis­
ited to check vaccination registries, partic­
ularly for preschool children, we consid­
ered only documented vaccination history,
which may have led to misclassification
since some vaccinated persons may not
have been recorded as such. It’s also likely
that there was some degree of recall bias
depending on outcome and interval be­
tween disease and interview. Finally, for
clinical features, we relied on the attend­
ing physician’s diagnosis using non-stan­
dardized procedures for recording signs,
complications (including confirmatory
tests, e.g., electrocardiograms and x-rays),
and cause of death, and medical charts of
varying quality for clinical variables. In
Garib et al. • Diphtheria in the Dominican Republic
spite of these limitations, we believe that
the main findings stand: the outbreak
affected mainly inadequately-vaccinated
persons living in poverty.
Conclusions
The current limited availability of DAT
in the world makes diphtheria occur­
rence extremely worrisome at this time
(8, 9). In the Americas, only the United
States currently has ready access to DAT,
but it is through a new investigational
drug protocol and the stock is very lim­
ited (19).
This last outbreak in the Dominican
Republic serves as a reminder that diph­
theria can result in unnecessary morbid­
ity and mortality. To prevent diphtheria
outbreaks, it is important to ensure high
and homogeneous vaccination coverage
and epidemiological surveillance sys­
tems that are able to detect diphtheria
cases early, allowing for prompt and ag­
gressive control measures.
Acknowledgements. We acknowledge
the health workers of the Dominican
Republic who were involved in outbreak
control and caring for the patients with
diphtheria. We also thank the Centers for
Disease Control and Prevention (Atlanta,
Georgia, United States) for conducting
the laboratory testing. Finally, we thank
Zunera Gilani for her initial data analy­
ses and Sergio Muñoz for reviewing the
final version of the statistical analyses in­
cluded in the manuscript.
Conflict of interests. None.
Disclaimer. Authors hold sole respon­
sibility for the views expressed in the
manuscript, which may not necessarily
reflect the opinion or policy of the RPSP/
PAJPH and/or PAHO/WHO.
REFERENCES
1. Vitek CR, Wharton M. Diphtheria toxoid.
In: Plotkin S, Orenstein W, Offic P, eds.
Vaccines. Amsterdam: Elsevier; 2008.
Pp. 139–56.
2.American Academy of Pediatrics.
Diphtheria. In: Pickering LK, Baker CJ,
Kimberlin DW, Long SS, eds. Red Book
2012: Report of the Committee on Infectious
Diseases. Elk Grove Village, IL: American
Academy of Pediatrics; 2012. Pp: 307–11.
3. Pan American Health Organization. Con­
trol of diphtheria, pertussis, tetanus,
Haemophilus influenzae type b, and hepa­
titis B. Field guide. Washington, DC:
PAHO, 2005. Available from: www.opsoms.org/English/AD/FCH/IM​/fieldguide_
pentavalent.pdf Accessed on 5 August
2015.
4. Vitek CR. Diphtheria. Curr Top Microbiol
Immunol. 2006;304:71–94.
5. Galazka A. The changing epidemiology of
diphtheria in the vaccine era. J Infect
Dis. 2000;181(suppl 1):S2–9.
6. Wagner KS, White JM, Lucenko I, Mercer
D, Crowcroft NS, Neal S, et al. Diphtheria
Surveillance Network. Diphtheria in the
postepidemic period, Europe, 2000-2009.
Emerg Infect Dis. 2012;18(2):217–25. doi:
10.3201/eid1802.110987
7. Pan American Health Organization. Vac­
cines and immunization, disease preven­
tion. Volume 1: Health in the Americas, 2002.
Washington, DC: PAHO; 2002. Available
from: www.paho.org/SaludenlasAmericas/
index.php?option=com_content&view=article
&id=10&Itemid=11&lang=en Accessed on 5
August 2015.
8. Pan American Health Organization. Diph­
theria outbreak in Haiti, 2009. Immu­niza­
tion Newsletter. 2009;31:1–3.
298
9. Wagner KS, Stickings P, White JM, Neal S,
Crowcroft NS, Sesardic D, et al. A review
of the international issues surrounding the
availability and demand for diphtheria
antitoxin for therapeutic use. Vaccine.
2009;28(1):14–20. doi: 10.1016/j.vaccine.
2009.09.094.
10. Pan American Health Organization. Vaccinepreventable diseases, health conditions
and trends. Volume 1: Health in the
Americas, 2007. Washington, DC: PAHO;
2007. Available from: www1.paho.org/hia/
homeing.html Accessed on 5 August
2015.
11.Pan American Health Organization.
Vaccine-preventable diseases, health con­
ditions and trends. Volume 1: Health
in the Americas, 2012. Washington, DC:
PAHO; 2012. Available from: www.paho.
org/SaludenlasAmericas/index.php?op­
tion=com_content&view=article&id=9
&Itemid=14&lang=en Accessed on 18
September 2015.
12. Pan American Health Organization. Im­
munization Data to 2005. Available from:
www.paho.org/hq/index.php?option=
com_content&view=article&id=2043
&Itemid=2032&lang=en Accessed on 18
September 2015.
13.Pan American Health Organization.
Diphtheria outbreak in the Dominican
Republic. EPI Newsletter. 2004;26:1.
Available from: www1.paho.org/english/ad/
fch/im/sne2603.pdf?ua=1 Accessed on 18
September 2015.
14. Dobbins J, St. Vil K, Alexandre G,
Hecdivert C, Hidalgo S, McMorrow M, et
al. Increase in reported diphtheria cases in
Haiti. Proceedings of the XVI Meeting of
the Technical Advisory Group on Vaccine-
preventable Diseases. Washington, DC:
PAHO; 2004. Available from: www.paho.
org/hq/index.php?option=com_content&
view=article&id=1862&Itemid=2032&
lang=en Accessed on 5 August 2015.
15. Population Division of the Economic
Commission for Latin America and the
Caribbean. Long term population esti­
mates and projections 1950-2100. Rev.
2013. Available from: www.cepal.org/
celade/proyecciones/basedatos_BD.htm
Accessed on 10 September 2015.
16. World Health Organization. Recommen­
ded surveillance standards for diphtheria.
Geneva: WHO; 2003. 17. Pan American Health Organization.
Vaccination Week in the Americas.
Washington, DC: PAHO; 2015. Available
from: www.paho.org/vwa/
18. Ropero-Álvarez AM, Kurtis HJ, DanovaroHolliday MC, Ruiz-Matus C, Tambini G.
Vaccination week in the Americas: an op­
portunity to integrate other health services
with immunization. J Infect Dis. 2012;
205(suppl 1):S120–5. doi: 10.1093/infdis/
jir773.
19. United States Centers for Disease Control
and Prevention. Diphtheria Antitoxin (DAT).
Available from: www.cdc.gov/diphtheria/
dat.html Accessed on 5 August 2015.
Manuscript received on 5 February 2015. Revised
version accepted for publication on 11 May 2015.
Rev Panam Salud Publica 38(4), 2015
Garib et al. • Diphtheria in the Dominican Republic
RESUMEN
Difteria en la
República Dominicana:
reducción de casos tras un
extenso brote epidémico
Palabras clave
Rev Panam Salud Publica 38(4), 2015
Original research
Objetivo. Describir el brote epidémico más reciente de difteria en la República
Dominicana, la incidencia de la enfermedad y la cobertura de la vacunación del 2004
al 2013.
Métodos. Se analizaron los datos clínicos de los casos de difteria acaecidos en el 2004
y que cumplieron con la definición de caso del estudio, junto con la información so­
cioeconómica y epidemiológica de las familias en las que aparecieron los casos. Se
llevaron a cabo análisis de una sola variable y de múltiples variables para evaluar los
factores de riesgo de difteria mortal. Se presentan los datos de vigilancia ordinaria y
cobertura vacunal.
Resultados. De enero del 2004 a abril del 2005, se notificaron un total de 145 casos de
difteria; 80 (66%) de los 122 casos notificados en el 2004 cumplieron con la definición
de caso; 26 fueron mortales (tasa de letalidad por caso: 32,5%). La incidencia más alta
(5,3 por 100 000) se produjo en el grupo de 1 a 4 años de edad; 62,5% fueron varones.
De los 80 casos, 61 (76%) se hospitalizaron en el Hospital A, 17 en el Hospital B, y 2 en
otros dos hospitales. La aparición más temprana (primera mitad del 2004), el orden
de nacimiento y la traqueotomía se asociaron con difteria mortal (P < 0 ,05); la proba­
bilidad de evolución mortal fue mayor en los casos ingresados en el Hospital A
(P = 0,066). La incidencia promedio anual de difteria fue de 4,91 casos por millón de
personas del 2000 al 2003, ascendió a 8,8 casos por millón durante los años 2004 y
2005, y descendió a 0,38 del 2006 al 2014; no se han notificado casos de difteria desde
el 2011. La cobertura de la vacunación con DTP3 varió de 72 a 81% del 2000 al 2004 y
de 81 a 89% del 2005 al 2013.
Conclusiones. El brote epidémico de difteria de los años 2004 y 2005 en la República
Dominicana ocasionó una importante morbimortalidad prevenible. Se produjo un
descenso en la incidencia de casos y no se han notificado nuevos casos en los últimos
años. El mantenimiento de una alta cobertura vacunal y de una vigilancia eficiente es
crucial para la prevención de los brotes epidémicos de difteria y el control de la
enfermedad.
Difteria; vacunacion; brotes de enfermedades; República Dominicana.
299